AlphaCrest Capital Management’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-23,060
| Closed | -$224K | – | 502 |
|
|
2022
Q3 | $224K | Sell |
23,060
-120,119
| -84% | -$1.17M | 0.01% | 1218 |
|
|
2022
Q2 | $2.08M | Buy |
143,179
+81,238
| +131% | +$1.18M | 0.1% | 296 |
|
|
2022
Q1 | $1.62M | Sell |
61,941
-8,282
| -12% | -$216K | 0.09% | 327 |
|
|
2021
Q4 | $2.78M | Buy |
70,223
+37,570
| +115% | +$1.49M | 0.1% | 259 |
|
|
2021
Q3 | $1.63M | Sell |
32,653
-8,494
| -21% | -$425K | 0.08% | 395 |
|
|
2021
Q2 | $2.28M | Buy |
41,147
+34,347
| +505% | +$1.91M | 0.1% | 315 |
|
|
2021
Q1 | $318K | Sell |
6,800
-10,900
| -62% | -$510K | 0.02% | 999 |
|
|
2020
Q4 | $770K | Buy |
+17,700
| New | +$770K | 0.06% | 430 |
|